HLTW.L vs. FBT.L
HLTW.L (Lyxor UCITS MSCI World Health Care TR C-USD) and FBT.L (First Trust NYSE Arca Biotechnology UCITS ETF Acc) are both Health & Biotech Equities funds - HLTW.L tracks the MSCI World/Health Care NR USD while FBT.L tracks the NASDAQ Biotechnology TR USD. Both are passively managed. Over the past 5 years, HLTW.L returned 4.29%/yr vs 6.96%/yr for FBT.L. At a 0.46 correlation, their price movements are largely independent. HLTW.L charges 0.30%/yr vs 0.60%/yr for FBT.L.
Performance
HLTW.L vs. FBT.L - Performance Comparison
Loading charts...
Different Trading Currencies
HLTW.L is traded in USD, while FBT.L is traded in GBp. To make them comparable, the FBT.L values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, HLTW.L achieves a -3.12% return, which is significantly lower than FBT.L's 8.70% return.
HLTW.L
- 1D
- 3.02%
- 1M
- 1.93%
- YTD
- -3.12%
- 6M
- -1.75%
- 1Y
- 11.48%
- 3Y*
- 5.29%
- 5Y*
- 4.29%
- 10Y*
- 7.69%
FBT.L
- 1D
- 4.42%
- 1M
- 9.49%
- YTD
- 8.70%
- 6M
- 7.12%
- 1Y
- 38.32%
- 3Y*
- 13.20%
- 5Y*
- 6.96%
- 10Y*
- —
HLTW.L vs. FBT.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
HLTW.L Lyxor UCITS MSCI World Health Care TR C-USD | -3.12% | 15.73% | 0.39% | 3.08% | -5.66% | 20.58% | 14.79% |
FBT.L First Trust NYSE Arca Biotechnology UCITS ETF Acc | 8.71% | 25.50% | 5.77% | 4.91% | -7.76% | -3.45% | 5.59% |
Correlation
The correlation between HLTW.L and FBT.L is 0.71, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.71 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.50 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.47 |
Correlation (All Time) Calculated using the full available price history since Jun 16, 2020 | 0.46 |
Over the past year, HLTW.L and FBT.L have become more correlated (0.71) than their long-term average of 0.46, meaning their price movements have been converging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HLTW.L vs. FBT.L — Risk / Return Rank
HLTW.L
FBT.L
HLTW.L vs. FBT.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Lyxor UCITS MSCI World Health Care TR C-USD (HLTW.L) and First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HLTW.L | FBT.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.02 | ||
| Sortino ratioReturn per unit of downside risk | -1.41 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.31 | -0.16 |
| Calmar ratioReturn relative to maximum drawdown | 1.14 | 2.64 | -1.51 |
| Martin ratioReturn relative to average drawdown | 2.84 | 7.17 | -4.33 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HLTW.L | FBT.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.79 | 1.81 | -1.02 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.30 | 0.40 | -0.10 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.52 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.75 | 0.35 | +0.40 |
Drawdowns
HLTW.L vs. FBT.L - Drawdown Comparison
The maximum HLTW.L drawdown since its inception was -26.58%, smaller than the maximum FBT.L drawdown of -33.79%. Use the drawdown chart below to compare losses from any high point for HLTW.L and FBT.L.
Loading charts...
Drawdown Indicators
| HLTW.L | FBT.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -26.58% | -33.79% | +7.21% |
Max Drawdown (1Y)Largest decline over 1 year | -10.12% | -14.43% | +4.31% |
Max Drawdown (3Y)Largest decline over 3 years | -19.19% | -20.15% | +0.96% |
Max Drawdown (5Y)Largest decline over 5 years | -19.19% | -29.92% | +10.73% |
Max Drawdown (10Y)Largest decline over 10 years | -26.58% | — | — |
Current DrawdownCurrent decline from peak | -5.90% | 0.00% | -5.90% |
Average DrawdownAverage peak-to-trough decline | -5.20% | -12.69% | +7.49% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.06% | 5.33% | -1.27% |
Volatility
HLTW.L vs. FBT.L - Volatility Comparison
The current volatility for Lyxor UCITS MSCI World Health Care TR C-USD (HLTW.L) is 4.82%, while First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L) has a volatility of 7.09%. This indicates that HLTW.L experiences smaller price fluctuations and is considered to be less risky than FBT.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HLTW.L | FBT.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.82% | 7.09% | -2.27% |
Volatility (6M)Calculated over the trailing 6-month period | 10.63% | 16.26% | -5.63% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.52% | 21.10% | -6.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.16% | 24.31% | -10.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 14.85% | 25.46% | -10.61% |
HLTW.L vs. FBT.L - Expense Ratio Comparison
HLTW.L has a 0.30% expense ratio, which is lower than FBT.L's 0.60% expense ratio.
Dividends
HLTW.L vs. FBT.L - Dividend Comparison
Neither HLTW.L nor FBT.L has paid dividends to shareholders.
Frequently Asked Questions
HLTW.L and FBT.L have a correlation of 0.71, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, HLTW.L is cheaper at 0.30% per year. The better choice depends on whether you care most about return, fees, risk, or income.
HLTW.L is cheaper with a 0.30% expense ratio, compared with 0.60% for FBT.L.
HLTW.L tracks MSCI World/Health Care NR USD, while FBT.L tracks NASDAQ Biotechnology TR USD. They also come from different issuers: Amundi and First Trust. Their fees differ too: 0.30% for HLTW.L and 0.60% for FBT.L.
Find the right allocation for HLTW.L and FBT.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer